Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The high prevalence of HLA-B5 in Behçet's disease.

Literature DB >> 606446

The high prevalence of HLA-B5 in Behçet's disease.

H Yazici, G Akokan, B Yalçin, A Müftüoğlu.

Abstract

Sixteen of the nineteen (84%) patients with Behçet's disease in Turkey had HLA-B5; the prevalence of HLA-B5 among 150 controls was 27%.

Entities: Disease Species

Mesh：

Substances：
HLA Antigens

Year: 1977 PMID： 606446 PMCID： PMC1541115

Source DB: PubMed Journal: Clin Exp Immunol ISSN： 0009-9104 Impact factor: 4.330

6 in total

1. Specific histocompatibility antigens associated with Behçet's disease.

Authors: S Ono; E Nakayama; S Sugiura; K Itakura; K Aoki
Journal: Am J Ophthalmol Date: 1975-10 Impact factor: 5.258

2. MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors: P I TERASAKI; J D MCCLELLAND
Journal: Nature Date: 1964-12-05 Impact factor: 49.962

3. Behçet's disease.

Authors: R E Curran
Journal: Ann Intern Med Date: 1972-02 Impact factor: 25.391

4. Behçet's disease. Report of 10 cases, 3 with new manifestations.

Authors: J D O'Duffy; J A Carney; S Deodhar
Journal: Ann Intern Med Date: 1971-10 Impact factor: 25.391

5. Behçet's syndrome with arthritis.

Authors: R M Mason; C G Barnes
Journal: Ann Rheum Dis Date: 1969-03 Impact factor: 19.103

6. HLA in Behçet's disease.

Authors: R T Jung; T M Chalmers; V C Joysey
Journal: Lancet Date: 1976-03-27 Impact factor: 79.321

6 in total

21 in total

Review 1. Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.

Authors: H Direskeneli
Journal: Ann Rheum Dis Date: 2001-11 Impact factor: 19.103

2. HLA and Behçet's disease in northern Spain: their lack of correlation with arthritis pattern.

Authors: J Sanchez Burson; J Graña Gil; M Rosales Rodriguez; A Atanes Sandoval; C Alonso Blanco; F Galdo Fernandez
Journal: Clin Rheumatol Date: 1992-06 Impact factor: 2.980

Review 3. Pulmonary vasculitis: classification, clinical features, and management.

Authors: A Ciaccia; M Ferrari; F M Facchini; G Caramori; L Fabbri
Journal: Clin Rev Allergy Immunol Date: 1997 Impact factor: 8.667

4. Is Behçet's disease triggered by childhood infection?

Authors: C Cooper; E C Pippard; H Sharp; C Wickham; M A Chamberlain; D J Barker
Journal: Ann Rheum Dis Date: 1989-05 Impact factor: 19.103

Review 5. Role of genetics in pediatric rheumatology.

Authors: Eda Tahir Turanlı; Elif Everest; Ayşe Balamir; Aslı Kireçtepe Aydın; Özgür Kasapçopur
Journal: Turk Pediatri Ars Date: 2017-09-01

6. HLA B5 and Behçet's disease.

Authors: H Yazici; M A Chamberlain; G M Schreuder; J Bird-Stewart; M Denman
Journal: Ann Rheum Dis Date: 1983-10 Impact factor: 19.103

7. The relationship of HLA-B and DR phenotypes to Behcet's syndrome, recurrent oral ulceration and the class of immune complexes.

Authors: T Lehner; K I Welsh; J R Batchelor
Journal: Immunology Date: 1982-12 Impact factor: 7.397

8. Neuro-Behçet's disease: a report of sixteen patients.

Authors: Radi Shahien; Abdalla Bowirrat
Journal: Neuropsychiatr Dis Treat Date: 2010-05-25 Impact factor: 2.570

9. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.

Authors: M Stanford; T Whittall; L A Bergmeier; M Lindblad; S Lundin; T Shinnick; Y Mizushima; J Holmgren; T Lehner
Journal: Clin Exp Immunol Date: 2004-07 Impact factor: 4.330

10. Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapy.

Authors: M L Pacor; D Biasi; C Lunardi; P Cortina; P Caramaschi; D Girelli; M Botto; G Urbani; G Lombardo; L M Bambara
Journal: Clin Rheumatol Date: 1994-06 Impact factor: 2.980